Literature DB >> 11100112

Will we have and why do we need an Ebola vaccine?

H D Klenk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11100112     DOI： 10.1038/82126

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.

Authors:  Jillian M Licata; Martha Simpson-Holley; Nathan T Wright; Ziying Han; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles.

Authors:  Jillian M Licata; Reed F Johnson; Ziying Han; Ronald N Harty
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Characterization of filovirus protein-protein interactions in mammalian cells using bimolecular complementation.

Authors:  Yuliang Liu; Sasha Stone; Ronald N Harty
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.